As an illustrative case in point, the intimate nexus between NF‐KATAB and BCL2 in ccRCC has not eluded the discerning gaze of scholars, intimating a compelling case for the effectiveness of NF‐KATAB as a therapeutic agent.34 This evidence concerns the gene BCL2 and nonpapillary renal cell carcinoma.